NCT01441297 2017-08-25BIBF 1120 as Second Line Treatment for Small Cell Lung CancerNational Cancer Center, KoreaPhase 2 Completed24 enrolled
NCT02152059 2016-07-06A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based ChemotherapyAHS Cancer Control AlbertaPhase 2 Withdrawn